CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
14 research outputs found
Paradoxes and Uncertainties of Immunomodulatory Treatments in the Fight Against Coronavirus Disease 2019
Author
Chen
Fox
+5Â more
Meyerowitz
Nienhold
Simonovich
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group
Vetter
Publication venue
'Oxford University Press (OUP)'
Publication date
Field of study
No full text
Crossref
Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis
Author
Beigel
Jeronimo
+10Â more
RECOVERY Collaborative Group
Röver
Seymour
Spiegelhalter
Spinner
Tomazini
Wang
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group
WHO Solidarity Trial Consortium
Writing Committee for the REMAP-CAP Investigators
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Corticosteroids in COVID-19 ARDS
Author
Alhazzani
Angus
+20Â more
Annane
Arabi
Ashbaugh
Bauchner
Bellani
Bhimraj
Dequin
Fang
Hallie C. Prescott
Horby
Iwashyna
Lee
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group
The Writing Committee for the REMAP-CAP Investigators
Todd W. Rice
Tomazini
Venkatesh
Villar
Wu
Ye
Publication venue
'American Medical Association (AMA)'
Publication date
Field of study
No full text
Crossref
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19
Author
BM Tomazini
C Huang
+14Â more
DC Angus
H Li
HK Siddiqi
L Shang
L Zha
P Horby
PF Dequin
R Fadel
R Kumar
R Salvi
S Zheng
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group
The Writing Committee for the REMAP-CAP Investigators
X Fang
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Global economic impact of antibiotic resistance: A review
Author
Ahmed
Antimicrobial Resistance Centre
+12Â more
Boston Consulting Group
Cecchini
Landers
MacLellan
OECD/WHO/FAO/OIE
Pallecchi
ReAct–Action on Antibiotic Resistance
Taylor
The World Bank
US Centers for Disease Control and Prevention (CDC)
US Centers for Disease Control and Prevention (CDC)
World Health Organization (WHO)
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia
Author
C. E. Minder
CD Russell
+24Â more
D. R. Cox
Dina Ragab
E Mahase
Eddy Fan
F. Zhao
Jose-Ignacio Pijoan Guillermo Ruiz-Irastorza
Leon Caly
M Edalatifard
M Scarsi
Na Zhu
Philippe Gautret
Pierre Kory
Puja Mehta
R Core Team
R Yang
RECOVERY Collaborative Group
S Arshad
S Deftereos
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group
TT Yao
Villar Jesús
Wu Chaomin
X Yao
Y Wang
Publication venue
'Public Library of Science (PLoS)'
Publication date
Field of study
No full text
Crossref
Effects of Multivitamin Supplement on Cataract and Age-Related Macular Degeneration in a Randomized Trial of Male Physicians
Author
Age-Related Eye Disease Study 2 (AREDS2) Research Group
Age-Related Eye Disease Study 2 Research Group
+63Â more
Age-Related Eye Disease Study Research Group
Age-Related Eye Disease Study Research Group
Age-Related Eye Disease Study Research Group
Agte
Arnold
Beatty
Berrow
Bone
Brown
Chasan-Taber
Chiu
Christen
Christen
Christen
Christen
Christen
Christen
Christen
Christen
Christen
Christen
Clinical Trial of Nutritional Supplements and Age-Related Cataract Study Group
Congdon
Cui
Ederer
Eye Diseases Prevalence Research Group
Fletcher
Gaziano
Gerster
Glynn
Gritz
Ham
Hennekens
Howard D. Sesso
J. Michael Gaziano
Jean MacFadyen
JoAnn E. Manson
Julie E. Buring
Krishnadev
Lyle
Ma
Mares-Perlman
McNeil
Miriam Schvartz
Moeller
Moeller
Olmedilla
Organisciak
Piermarocchi
REACT Group
Robert J. Glynn
Seddon
Sesso
Sperduto
Steering Committee of the Physicians' Health Study Research Group
Taylor
Taylor
Teikari
Teikari
Tso
Vadim Bubes
Vu
William G. Christen
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
An ideal ocular nutritional supplement?*
Author
Ascherio A.
Azzi A.
+83Â more
Balz F.
Beatty S.
Bendich A.
Berendschot T.
Bielski B.
Bird A. E. C.
Blumenkranz M. S.
Blumenthal M.
Bone R. A.
Bressler N. M.
Brown L.
Burton G.
Burton G.
Chasan-Taber L.
Curcio C.
Defeudis F.
Delcourt C.
EDCCS Group
Evans J. R.
Expert Group on Vitamins and Minerals
Freudenheim J.
Friedrichson T.
Fukuzawa K.
Goldberg J.
Group TI-ACS
Halliwell B.
Ham W. J.
Hammond B. R.
Hankinson S.
Hathcock J.
Hawkins B. S.
Houtkooper L.
Hunt D.
Jacques P.
Jacques P.
Jacques P. F.
Jung F.
Le Marchand L.
Lebuisson D. A.
Leske M.
Leske M.
Levin G.
Lui N.
Lyle B.
Lyle B.
Machlin L.
Machlin L.
Mares-Perlman J.
Mares-Perlman J. A.
Martin H.
Mason P.
Melhus H.
Moseley M.
Newsome D. A.
Nishikimi M.
Ozawa T.
Packer L.
Packer L.
Pincemail J.
Pippenger C.
Primary Prevention Project
Rapp L. M.
Richer S.
Robertson J.
Robinson W.
Sies H.
Singh S.
Snodderly D. M.
Stur M.
Taddei S.
Teikari J. M.
The AREDS Research Group
The AREDS Research Group
The ATBC Cancer Prevention Study Group
The REACT Group
Valero M.
VandenLangenberg G. M.
Vitale S.
Vitale S.
Weber F.
West S.
Yeum K.-J.
Zile M.
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
The effect of tocilizumab on cytokine release syndrome in COVID-19 patients
Author
A Hassoun
AR Morrison
+32Â more
B Cao
B Fu
B Russell
B Uysal
C Campochiaro
C Huang
C Quin
C Zhang
CC Price
D McGonagle
EG Favalli
F Zhou
G Guaraldi
HK Siddiqi
J Alijotas-Reig
JG Rizk
JJ Zhang
KJ Clerkin
L Quartuccio
M Cardone
P Horby
PK Bhatraju
Q Ruan
S Ramiro
S Sciascia
SR Bonam
SR Bonam
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group
V Morena
W Alhazzani
X Mingxuan
Z Wu
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Clinical pathways and management of antithrombotic therapy in patients with acute coronary syndrome (ACS): a Consensus Document from the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Society of Emergency Medicine (SIMEU) and Italian Society of Interventional Cardiology (SICI-GISE)
Author
ACCA study group on pre-hospital care
+74Â more
ACCOAST Investigators
ACTION Group
ACTION Study Group
ACUITY Investigators
ACUITY Investigators
ADMIRAL Investigators
American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards
ATLANTIC Investigators
ATLAS ACS 2–TIMI 51 Investigators
ATOLL Investigators
Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 Investigators
Canadian Acute Coronary Syndrome Registry I and II Investigators
Canadian Acute Coronary Syndromes I and II
CHAMPION Investigators
CHAMPION PHOENIX Investigators
Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators
Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial
CREDO Investigators
CRUSADE Investigators
CURRENT-OASIS 7 trial investigators
EARLY ACS Investigators
ESC Committee for Practice Guidelines
EUROMAX Investigators
EUROTRANSFER Registry Investigators
ExTRACT-TIMI 25 Investigators
EYESHOT Investigators
FABOLUS PRO Investigators
FINESSE Investigators
FIR Collaboration
for the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)
Francesco Rocco Pugliese
Francesco Romeo
Furio Colivicchi
FUTURA/OASIS-8 Trial Group
Gian Alfonso Cibinel
Giuseppe Musumeci
GRACE Investigators
HEAT-PPCI trial investigators
HORIZONS-AMI Trial Investigators
HORIZONS-AMI Trial Investigators
HORIZONS-AMI Trial Investigators
HORIZONS-AMI Trial Investigators
ICTUS Investigators
Invasive versus Conservative Treatment in Unstable coronary Syndromes Investigators
ISAR-REACT 4 Trial Investigators
Leonardo De Luca
Maria Pia Ruggieri
MATRIX Investigators
Michele Massimo Gulizia
National Cardiovascular Data Registry
OASIS 5 and 6 Investigators
OASIS-6 Investigators
OASIS-6 Trial Group
Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group
Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group
PEGASUS-TIMI 54 Steering Committee and Investigators
PLATelet inhibition and patient Outcomes Investigators
PLATO Investigators
PLATO Study Group
PLATO Study Group
STREAM Investigative Team
SWAP Investigators
SYNERGY Investigators
SYNERGY Trial Investigators
The SYNERGY Trial Investigators
TRA 2P–TIMI 50 Steering Committee and Investigators
TRACER Investigators
TRILOGY ACS Investigators
TRITON-TIMI 38 Investigators
TRITON-TIMI 38 investigators
TRITON-TIMI 38 Investigators
TRITON-TIMI 38 Investigators
USIK USIC 2000 Investigators
‘A to Z’ Investigators
Publication venue
'Oxford University Press (OUP)'
Publication date
Field of study
No full text
Crossref
1
2